Sonova Raises Full-Year Guidance After First-Half Revenue Growth
Revenue rose 6.7% to 1.83 billion Swiss francs in the first half of fiscal 2026/27. Sonova now targets full-year revenue growth of 6–8% and core EBIT growth of 10–13% at constant exchange rates.
Sonova announced strong financial results for the first half of the 2026/27 fiscal year, ending in September, with revenue reaching 1.83 billion Swiss francs, a 6.7% increase (7.5% in local currencies). The growth was primarily fueled by the hearing care business, which benefited from higher sales volumes and increased average selling prices. The company highlighted the successful launch of its new Phonak Audéo EON hearing aid platform, which features integrated real-time AI and has exceeded initial sales expectations.
Due to the strong performance, Sonova raised its full-year guidance, now targeting revenue growth of 6-8% and core EBIT growth of 10-13% at constant exchange rates. Conversely, the cochlear implant division saw a 10.2% decline in revenue in local currencies, attributed to lower system sales in China and the United States.